Skip to main content
. 2020 Jan 22;28(10):4753–4760. doi: 10.1007/s00520-019-05276-0

Table 2.

Complication frequency in relation to use

Use Frequency of use Complication rate
Exclusively for chemotherapy 360 (69%) 38 (7.3%)
Exclusively for immunotherapy 31 (5.9%) 12 (2.3%)
Exclusively for parenteral feeding 42 (8.0%) 8 (1.5%)
Chemotherapy and parenteral feeding 51 (9.8%) 9 (1.7%)
Immunotherapy and parenteral feeding 16 (3.1%) 3 (0.6%)
Other 22 (4.2%) 5 (1.0%)
Overall 522 75 (14.4%)